Isracann Biosciences (IPOT.C) is accelerating efforts to service an anticipated increase in demand for both domestic and EU markets. Isracanna is Israel’s only pure pot
“We have achieved a partnership agreement with a farm operation that is constructed,” stated Isracann CEO, Darryl Jones, “it has already closed a major offtake agreement for the next three years. This accelerates our timeline to production and revenue.”
There’s a lot going on underneath the surface with Isracann Biosciences (IPOT.C). A year in review won’t be much, mostly because this company hasn’t been
On December 17, 2019 Isracann (IPOT.C) announced that it has entered into an Memorandum of Understanding (MOU) for a joint venture (JV) with an additional
Isracann BioSciences (IPOT) is the first pure pot play growing in the Promised Land. You may not think this middle east nation state is a
Isracann Biosciences (IPOT.C) got the regulatory nod from the Israeli Land Authority for their land use and facility design, but before they can get started
Isracann Biosciences (IPOT.C), an Israel-based cannabis play, has engaged the services of LinC by Growing Smart to draw a project roadmap for their proposed 230,000
Being “original” in business is a double-edged sword. Yes – it’s good to stand out in the crowd. But – when you’re all alone –
As a general rule, I’m against any company with ‘cann’ or ‘canna’ in its title. You could make a drinking game out of reading the
A few days ago, I published a story about our friends from HIKU/Tokyo Smoke/Doja/Saxx who, having exited from their last company with a $400m+ acquisition
